You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凯普生物(300639.SZ):公司及子公司获得1项发明专利授权
格隆汇 12-02 16:05

格隆汇12月2日丨凯普生物(300639.SZ)公布,公司以及子公司在2024年11月获得1项发明专利授权,发明专利名称为一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法。

该发明专利公开了一种从孕妇宫颈脱落细胞中分离胎盘滋养层细胞的方法,该方法基于滋养层细胞表面或胞内表达的特异性抗原及组合,并利用设计的微流控分选芯片或流式细胞仪,对孕妇宫颈脱落细胞样本所制备的细胞悬浮液进行分选,从而获得纯化的胎盘滋养层细胞。本发明与传统方法相比,具有无创获取标本和特异性好的优势,该方法取材时间较传统检测方法更早,可能引起的感染及流产的风险更低,能实现同时对多个抗原进行同步标记,并对多个特征信号进行识别和分选。该方法提高了检测的准确性,检测结果具有更高的可信度和更广的覆盖范围。本发明将应用于产前筛查和产前诊断领域,目前已取得中国、美国、日本、俄罗斯、巴西、韩国、澳大利亚以及欧洲等国家或地区颁发的发明专利证书,是公司细胞分选项目的首个成果。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account